跳至主要内容
临床试验/CTRI/2021/06/033950
CTRI/2021/06/033950尚未招募3 期

An Open Label, Clinical Validation Study to Evaluate the Efficacy and Safety of Unani Pharmacopoeial Formulation Qurs e Atash in Humuzat e Meda(Hyperacidity)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects of either sex in the age group of 18-65 years
  • 2. Subjects presenting with any of the following symptoms:
  • Retrosternal burning
  • Epigastric pain with retrosternal heaviness
  • Nausea or Vomiting
  • SourBelching
  • Sour/Bitter Taste
  • Indigestion

排除标准

  • 1. Pregnant/Lactating women
  • 2. History of previous GIT surgery
  • 3. History of Hematemesis orMelena
  • 4. Any systemic diseases like Cardiovascular, Respiratory, Hepato-Biliary and Renal Diseases
  • 5. Any metabolic diseases like Diabetes
  • 6. Chronic tobacco chewers or smokers
  • 7. Alcoholism
  • 8. Allergy/Hypersensitivity to any ingredients of the drug.
  • 9. Known cases of Peptic Ulcer disease, Crohnâ??s Disease, Zollinger-Ellison Syndrome and Carcinoma of gastro-intestinal tract

研究者

发起方
Central Council for Research in Unani Medicine CCRUM New Delhi

相似试验

Treatment of acidity with Unani medicine Qurs-e-Atash | 临床试验